Products - Hypertension | Topic

Showing 4 products

Date | Title

Secondary care management of malignant hypertension
Status:
Awaiting development
Expected publication date:
TBC
Treprostinil diethanolamine for treating pulmonary arterial hypertension [TSID11772]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Aprocitentan for treating resistant hypertension [ID6681]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Percutaneous transluminal renal sympathetic denervation for resistant hypertension
Status:
Awaiting development
Programme:
HealthTech guidance
Expected publication date:
TBC